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Background: Medication oversupply is an important problem in the healthcare systems. It causes unnecessary
avoidable healthcare costs. Although some studies have determined the magnitude and financial loss due to
medication oversupply in western countries, they may not be applicable to Asia-pacific countries. This study aims to
determine the prevalence, financial loss, and patterns of medication oversupply and the factors associated with
such oversupply in Thailand.
Methods: A retrospective database analysis was used from 3 public hospitals. Patients visiting the outpatient
department of the hospitals in 2010 and receiving at least 2 prescriptions within 6 months were included. The
modified medication possession ratio (MPRm) was used to determine the medication supply. Patients having
MPRm > 1.20 were defined as receiving a medication oversupply. The measures were prevalence of medication
oversupply, the number of oversupplied medications, and financial loss (2012 dollars) due to medication
oversupply. Hierarchical logistic regression was used to determine the factors associated with the prevalence of
medication oversupply.
Results: A total of 99,743 patients were included. Patients were on average 49.7 ± 21.2 years of age, and 42.8%
were male. Most of them were adult (53.7%). Among those patients, 60.2% of the patients were under universal
coverage schemes. Around 13.4% of all the patients received a medication oversupply, and the patients in regional
hospitals had a higher prevalence of medication oversupply than patients in district hospitals (13.8% VS 8.2%). The
patients under civil servant medical benefit schemes (CSMBS) (13.6%) had the most prevalence of medication
oversupply. The total financial loss was $189,024 per year. The average financial loss was $1.9 ± 19.0 per patient/
year. Patients under CSMBS experienced the highest average financial loss (2.6 ± 23.2 $/patient/year). Age, gender,
health insurance schemes, and the number of medications that the patients received were the factors associated
with medication oversupply.
Conclusions: Medication oversupply is an important problem for the health system. Patients receiving care from
regional hospitals had a higher likelihood of medication oversupply. Policymakers may consider developing policies
for preventing medication oversupply. The policy should be implemented in regional hospitals and especially in
children or patients with poly-pharmacy.
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Many countries are facing substantial increases in drug
expenditure [1]. This is likely attributable to multiple
factors, including the advance of technology that has
brought with it higher costs, the aging of the population,
and changes in prescribing practices [2-6]. However, one
of the important understudied factors is medication
oversupply [7].
Medication oversupply occurs when patients receive
an amount of medication that exceeds what they need
[8]. It is an important problem in the healthcare systems
in several countries. The prevalence of medication over-
supply was 12%-22% [9,10] in Sweden and 30%-47% in
the USA [11-14]. In Thailand, the prevalence of medica-
tion oversupply has been estimated to range from 5.9% -
47.2% [7,15].
Medication oversupply causes unnecessary avoidable
healthcare costs. A study conducted in the USA indi-
cated that patients receiving a medication oversupply
spent more on medication than patients with a proper
supply at around 14% [11] for only 12 medication class.
In Sweden, the extra cost due to medication oversupply
was approximately 4.3% of the total medication cost
[16]. Furthermore, medication oversupply may increase
the risk of adverse clinical consequences. Several studies
have revealed that patients with a medication oversupply
had higher risks of hospitalization than those with a
proper supply [7,9,10,17]. Further, a study conducted
with patients with type 2 diabetics reported that patients
receiving a medication oversupply were 5% less likely to
achieve recommended levels of their hemoglobin A1C
than patients with a proper supply [18].
Since the majority of previous studies were conducted
in developed countries, the findings might not be applic-
able to developing countries. Healthcare systems in de-
veloping countries might be different from those of
developed countries, including lack of controls in the
supply system for medications. For example, in Thailand
there is no utilization management procedure in place
to discourage or prevent early or excessive refilling of
medications. Day supply limits, which are common in
developed countries, prevent excessive medication refills
by not allowing excessive medication refills for patients
and are not common in Thailand. Thus, the findings
on medication oversupply in developed countries might
not be applicable to developing countries, including
Thailand where oversupply may be an even bigger prob-
lem for the healthcare system.
Although some prior studies have been conducted to
determine the prevalence and financial burden due to
medication oversupply in Thailand, they were conducted
in a single hospital and focused on a limited number of
medications [7,15]. One of them was conducted at a uni-
versity teaching hospital, while another was conductedat a regional hospital that focused only on the 5 medica-
tions that were responsible for the highest expenditures.
In Thailand, there are 4 major types of hospitals: 1) uni-
versity hospitals, which usually serve patients with very
severe and complex diseases; 2) regional hospitals, which
commonly serve patients with a wide-range of complex
and severe diseases; 3) general hospitals, which also
serve patients with any diseases of lower complexity and
severity; and 4) district hospitals, which serve patients
with non-complicated diseases. In 2010, the government
hospitals in Thailand consisted of 93 regional/general
hospitals covering all provinces in Thailand, 731 district
hospitals, and over 9,700 Tumbon Health Promoting
Hospitals (THPHs) [19] or sub-district health centers
along with a network of urban and rural community
primary healthcare centers and village health volunteer
systems [20,21]. Because of the differences in service
among the types of hospitals, previous studies might not
be generalizable to other types of hospitals. Moreover,
previous studies did not identify the factors affecting
medication oversupply, which could lead to targets for
interventions. Thus, this study aimed to determine the
patterns of medication oversupply, its financial burden,
and its associated factors in Thailand.
Methods
Data sources
A retrospective database analysis was conducted from
the healthcare payer perspective. Electronic databases
obtained from 3 hospitals were used. In conducting this
study, the authors had access to data from three hospi-
tals in the northern part of Thailand. Two hospitals were
regional hospitals, located in the northern part and
northeastern part of Thailand. Another hospital was a
district hospital located in the northern part of Thailand.
In order to increase the generalizability of the findings,
both regional and district hospitals, which serve a differ-
ent case-mix of patients, were included. The electronic
databases included demographic databases, outpatient
diagnostic databases, and pharmacy databases. They
contained information on age, sex, health insurance, date
of birth, International Statistical Classification of Dis-
ease, 10th Revision [ICD-10], visit date, drug name, drug
code, drug regimen, and the amount of medication per
prescription. This study was approved by the Naresuan
University Human Ethics Committee and the ethics
committee of each hospital which were Buddhachinaraj
hospital, Sunpasitthiprasong hospital, and Nakhon Thai
Crown Prince hospital.
Patient and study period
The authors identified all of the patients visiting the out-
patient departments (OPD) of the three hospitals in
2010. The inclusion criteria were the following: 1)
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Dec 31st, 2010; 2) patients receiving at least 2 prescrip-
tions within 6 months for the same specific generic
name of medications; 3) patients receiving any medica-
tion for chronic conditions. Patients were followed up
from the first date of receiving the medications until the
last of the medication dispensation or Jun 30th, 2011.
Medication supply measurements
Medication supply was measured using the modified
medication possession ratio (MPRm) for each medica-
tion that the patients received. The medications that
patients received only one time were excluded from the
analysis. The MPRm was calculated by dividing the total
days’ supply of a specific generic name of medication
for a patient by the number of days from first to last
dispensation, plus the number of days’ supply in last
dispensation. We defined our operational definition of
medication oversupply (MPRm > 1.20) based on two rea-
sons. First, we selected 120% to represent a potentially
clinically significant oversupply of medications. Several
studies indicated that the cut-off point of non-adherence
should be 80% of perfect adherence (20% difference
from perfect adherence), which affects the morbidity
and mortality in several diseases [22-24]. We felt that a
20% difference from perfect adherence (100%) may also
be meaningful in terms of medication oversupply. While
there are no studies that have evaluated the clinical
significance of this value, we felt that the absolute differ-
ence of 20% was a reasonable estimate for identifying
someone with an oversupply of medication. Second, we
considered the issue of medication supply management.
It is reasonable that patients are allowed some additional
medications to allow for medication loss or delayed
refill. In the US insurance companies often allow for a
7-day overlap of a refill for a medication with a 30-day
supply. The 7-day overlap allowance for a medication
with a 30-day supply is about a 23% overlap. Based on
these two reasons, we considered that the MPR > 1.20
(>20% overlap) was the cut-off value for determining
medication oversupply. Patients were identified as hav-
ing an appropriate supply when they had an MPRm
between 0.80 -1.20 in all of the medications that the
patients received. Since patients usually received more
than one medication, we classified patients as having
medication oversupply if at least one of the MPRms
was >1.20, the cut-off which has been used in previous
literatures [8,11,14,16].
The MPRm was slightly modified from the medication
possession ratio (MPR) by changing the denominator of
the formula from a pre-specified time period (such as 1-
year follow-up period) to the number of days from first
to last dispensation, plus the number of days’ supply in
the last dispensation [15,25,26].MPRm ¼ Total days supplied
last dispensation date−first dispensation dateð Þ
þnumber of days′supply in last dispensation
x 100
All of the patients were traced to determine the medica-
tion supply that each patient received. The index date of
each medication was determined according to the first dis-
pensation date of each specific medication. Patients that
met the inclusion criteria were traced from the index date
to the last dispensation date of each specific medication
(Figure 1). For instance, patient A received 3 medications.
The 1st medication was dispensed from January 1st to
October 31st, 2010. The 2nd medication was dispensed
from February 1st to November 30th, 2010. The last one
was dispensed from November 15th, 2010 to June 30th,
2011. The patient was traced from January 1st, 2010 to June
30th, 2011 and the medication supplies of the patient were
calculated for each specific generic name of medication.
The MPRm for each specific generic name of medica-
tion, except for transdermal medications and eye, ear,
and nasal drops, was calculated in this study. We ex-
cluded transdermal medications, eye, ear, and nasal drop
out of our study because they have no exact dose of ad-
ministration and the MPRm could not be calculated.
Medications prescribed for use as needed and immediate
use were also excluded because they could not be used
to calculate the MPRm.
Outcome measures of interest
The primary outcome measure of interest was the preva-
lence of patients having a medication oversupply. Second-
ary outcome measures were the number of oversupplied
medications, and financial loss due to medication oversup-
ply. The prevalence of patients experiencing a medication
oversupply was defined as the proportion of patients that
had an MPRm> 1.20 over the total number of patients.
Patients that had an MPRm 0.8-1.2 were identified as
having an appropriate supply and patients that had an
MPRm< 0.8 were identified as having an undersupply.
The number of oversupplied pills was presented as the
total number of oversupplied pills and the average number
of oversupplied pills per patient. Financial loss due to
medication oversupply was determined by the number of
oversupplied pills multiplied by the reference costs of each
medication purchased during the year 2012 [27]. Financial
loss was converted to US$ using an exchange rate of 29.42
baht/US$ [28]. The cost was annualized to 1 year cost.
Data analysis
Descriptive statistics were used to describe the baseline
characteristics and outcome measures of interest. Sensitiv-
ity analysis was also performed by varying the definition of
Figure 1 Index date, patient tracing, and study period. Legend: This figure illustrates how the patients in this study were followed up. For
example, patient A received in total 3 medications (Med-1, Med-2, and Med-3). We followed patient A from Jan 2010 to Jun 2011 but we tracked
data for medication 1 of patient A until the last dispensation date. We also tracked the data for each medication that patient A received. We
calculated the modified medication possession ratio (MPRm) for each medication that patient A received based on the first and last date of
dispensation. Thus, patient A had 3 MPRms. We classified patient A as oversupplied if any MPRm of patient A >1.20.
Figure 2 The flow of patient selection.
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group analysis was performed by type of hospitals (re-
gional vs. district), and health insurance (universal health
coverage schemes (UCS), social security schemes (SSS),
civil servant medical benefit schemes (CSMBS), and other
insurances. We used the type of hospital for the subgroup
analysis because different hospitals have different out-
patient medication management systems. It may affect
outcomes in this study. In our study, we used 2 types of
hospital as regional and district hospitals. We also used
health insurance for the subgroup analysis. In Thailand,
there are 3 main health insurances, including the UCS,
SSS, and CSMBS. Conceptually, the UCS and SSS employ
capitation payment, while the CSMBS is fee-for-service
payment. That might affect the patterns of the prescrip-
tions prescribed and oversupply of medication. Chi-square
statistic was used to examine the difference in the
number of oversupplied patients among subgroups.
The Mann–Whitney U-test or the Kruskal-Wallis test
was used to examine the difference in financial loss
among subgroups.
To determine the factors associated with medication
oversupply, we used hierarchical logistic regression be-
cause the data structure we used fit the model. The
individual-level data (lower-level) nested in the hospital
level variable (upper-level). The dependent variable was
having a medication oversupply for each patient. Patients
having a medication oversupply were compared to the
appropriately-supplied patients. The undersupplied-
patients were not considered in the factor association
analysis. The primary reason was that we were only
interested in investigating the factors determining pa-
tients having an oversupply. Having an appropriate
supply as a comparator would help us understand the
differences between these two groups. In addition, we
could treat oversupply as a dependent dichotomous
variable. We used type of hospital as a random-effects
variable and used age group (children/adolescent,
adult, and elderly), gender, health insurance, Charlson’s
co-morbidity index (an algorithm commonly used for
assessing the comorbidity burden of patients) [29], andnumber of medications patients received (<5 vs ≥5
medications) as fixed-effects variables. All of the fixed-
effects variables were included in the model as these
were identified as important factors in our literature
review. A generalized chi-square was used to assess the
goodness of fit of the model (A generalized chi-square
per degree of freedom <2.0 indicates no lack of fit).
Results
We identified 276,756 patients visiting an OPD in 2010.
Among those, 99,743 patients met the inclusion criteria
(Figure 2). Patients were on average 49.721.2 years of
age with 42.8% being male. Most of them were adults
(53.7%). Among those patients, 60.2% of the patients
were under a UCS. The detailed baseline characteristics
are shown in Table 1. The pattern of medication supply
is shown in Table 2. The percentage of patients that had
a medication oversupply was 13.4%, while 47.7% of the
patients had an appropriate supply. On average, the
number of days’ supply was 354.7 ± 247.3 days for
Table 1 Baseline characteristics
Patient characteristics Number of patients (%)
(N = 99,743)
Type of hospital
Regional hospital 91,614 (91.9)
District hospital 8,129 (8.2)
Age (Mean ± SD) 49.7 ± 21.2
Children/adolescent (<18 years old) 10,799 (10.8)
Adult (18–59 years old) 53,564 (53.7)




Missing data 232 (0.2)
Health insurance 60,026 (60.2)
Universal health coverage schemes 7,760 (7.8)
Social security schemes 29,203 (29.3)
Civil servant medical benefit schemes 2,522 (2.5)
Others 232 (0.2)
Missing data
Charlson’s co-morbidity index 1.1 ± 1.7





Abbreviations: SD standard deviation.







Number of patients (%) 38,881 (39.0) 47,527 (47.7) 13,324 (13.4)
Average day
supply (days)
260.7 ± 185.1 371.1 ± 185.1 354.7 ± 247.3
Average follow-up
time (days)
334.4 ± 169.3 365.9 ± 180.1 331.0 ± 18.6
Average MPRm 0.6 ± 0.3 1.0 ± 0.7 1.2 ± 0.6
Average number of
medication receipts
5.2 ± 3.4 3.9 ± 2.7 6.2 ± 4.4
Average oversupplied
items per patient
N/A N/A 0.3 ± 0.5
Abbreviations: MPRm modified medication possession ratio, N/A not applicable.
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supplied patients. The average number of medication
items received was 6.2 ± 4.4 and 3.9 ± 2.7 for oversup-
plied and appropriately-supplied patients, respectively.
Magnitude of medication oversupply
There were 13.4% of patients that had a medication
oversupply (13,330/99,743 patients). The total oversup-
plied pills/units were 785,223 pills/units or 7.9 ± 68.6
pills/units per patient per year. The prevalence of medi-
cation oversupply was 22.7% when the definition of
medication oversupply was changed to MPRm >1.10
(Table 3).
The prevalence of medication oversupply in the re-
gional hospitals was higher than that in the district
hospitals (13.8% VS 8.2%; p < 0.001). The problem of
medication oversupply was slightly different among dif-
ferent health insurance schemes. Among the patients
under the UCS, 8,061 of 60,026 (13.4%) patients had a
medication oversupply, while the patients under the SSS
and CSMBS were at 11.6% and 13.6%, respectively (p <
0.001) (Table 3).Financial loss due to medication oversupply
The total financial loss due to medication oversupply
was $189,024 per year or $1.9 ± 19.0 per patient/year.
The overall medication expenditure of the entire cohort
was $16,533,401. The total financial loss due to medica-
tion oversupply accounted for 1.1% of total outpatient
drug expenditure. When the definition of medication
oversupply was changed to MPRm > 1.10, the financial
loss increased to $307,552 (1.9% of total expenditure).
The average financial loss was 1.9 ± 9.0 and 5.2 ± 31.6
$/patient/year for MPRm >1.20, and >1.10, respectively
(Table 3).
Financial loss due to medication oversupply at the re-
gional hospitals was higher than that of the district hos-
pitals. The total financial loss at the regional hospitals
was 93,030 $/hospital, while the total financial loss at
the district hospitals was 2,963 $/hospital. The average
financial loss was 2.0 ± 19.8 $/patient/year in the re-
gional hospitals, while the average financial loss was 0.4
± 4.1 $/patient/year in the district hospitals (p < 0.001)
(Table 3). The average financial loss for patients under
the CSMBS (2.6 ± 23.2 $/patient/year) was higher than
that of patients under the UCS (1.7 ± 18.1 $/patient/
year) and SSS (1.1 ± 9.0 $/patient/year) (p = 0.004).
Factor associated with medication oversupply
The generalized chi-square per degree of freedom was
1.01, which indicated no lack of fit. Based on our multi-
variate hierarchical logistic regression model, children
and adolescent patients had a higher risk of being over-
supplied with medications than adult patients (adjusted
odds ratio (AOR) 3.303; 95% confidence interval (CI),
3.095 – 3.525)), while elderly patients tended to have a
higher risk compared to adult patients but this was
not statistically significant (AOR 1.039 (95% CI; 0.992-
1.088)). Female patients were at higher risk of being
oversupplied with medications than male patients (AOR;
1.177 (95% CI; 1.131-1.226). Patients under the SSS were
at higher risk compared to patients under the UCS












MPRm >1.20 13.4 785,223 7.9 ± 68.6 189,024 1.89 ± 19.04
MPRm >1.10 22.7 1,584,955 15.9 ± 91.8 307,552 5.24 ± 31.61
By type of hospital (MPRm> 1.20)
Regional hospital 13.8 771,727 8.4 ± 71.1 93,030* 2.03 ± 19.82
District hospital 8.2 13,496 1.7 ± 28.4 2,963 0.36 ± 4.14
By health insurance (MPRm> 1.20)
UCS 13.4 470,620 7.8 ± 66.7 101,280 1.7 ± 18.1
SSS 11.6 34,976 4.5 ± 37.7 8,669 1.1 ± 9.0
CSMBS 13.6 249,456 8.5 ± 60.5 76,030 2.6 ± 23.2
Others 13.3 28,719 11.4 ± 181.6 2,810 1.1 ± 8.1
Missing 23.7 1,452 6.7 ± 23.1 234 1.0 ± 5.5
Abbreviations: CSMBS civil servant medical benefit schemes, MPRm modified medication possession ratio, SSS social security schemes, UCS universal
coverage schemes.
*Financial loss per hospital.
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under the CSMBS had a similar risk of medication over-
supply compared to patients under the UCS (AOR 1.030
(0.982-1.079)). The patients that received medications 5
items or more (also called poly-pharmacy) were at
higher risk of being oversupplied with medications than
patients that received fewer than 5 medications (AOR
2.625 (95%CI; 2.507-2.748)). Patients visiting regional
hospitals tended to receive more oversupplied medica-
tion than patients visiting district hospitals, but this was
not statistically significant (AOR 1.235 (95%CI; 0.056 –
27.027)) (Table 4).
Discussion
This study demonstrated that medication oversupply is
an important problem in the healthcare system in
Thailand. Around one-seventh of patients had an ex-
cess supply of medications based on the days’ supply
they were dispensed and their government experienced
unnecessary financial loss due to this medication
oversupply.
Comparing the prevalence of patients having medica-
tion oversupply in our study with that in a previous Thai
study conducted in a teaching hospital, the prevalence
found in our study was around 2.3 times higher. There
were likely two possible reasons for this. First, the defin-
ition of medication oversupply in our study differed
from that in the previous study. The definition of medi-
cation oversupply in this study was MPRm > 1.20, while
in the other study it was more than 30 days left. Second,
the drug utilization patterns in regional and district hos-
pitals might be different from those in teaching hospi-
tals. A teaching hospital usually has a large number of
medical specialists and specialty clinics that may causedifferences in drug utilization patterns compared to
other types of hospitals. In addition, the prevalence
of patients having a medication oversupply in the teach-
ing hospital is relatively low because patients visiting
a teaching hospital might not adhere to care at the
hospital—they may seek care at other hospitals close to
their homes.
The total financial loss due to medication oversupply
in this study was not substantial. The financial loss was
1.1% of total OP drug expenditure. This finding was
different from that of Kaojarern’s study [15], which re-
ported that the financial loss accounted for 2.6% of total
oral OP drug expenditure. This was likely due to the dif-
ference in definition of medication oversupply. Although
the total financial loss was not tremendous, it would be
better for the government to prevent unnecessary finan-
cial loss due to medication oversupply and spend the
saved money to improve the healthcare system. More-
over, it is important to note that our study determined
only direct financial loss. The indirect financial loss due
to medication oversupply might also affect the govern-
ment’s budget. Again, the unnecessary financial loss due
to medication oversupply could be preventable.
The subgroup analysis indicated that regional hospitals
had a higher prevalence of patients having a medication
oversupply and also greater financial loss. This difference
was likely due to the large number of patients visiting
the hospitals, which leads to a greater workload on the
part of healthcare workers. Because of this high work-
load, healthcare providers might not pay attention to
reviewing the amounts of medications dispensed. More-
over, patients with more complex diseases and the more
sophisticated health service systems in the regional hos-
pitals might affect the quality of care in those hospitals.
Table 4 Factors associated with medication oversupply
(MPR >1.20)
Factors Adjusted odds ratio
(95% CI)
Age group
Adult (18–59 years old) Reference
Children/Adolescent (<18 years old) 3.303 (3.095 - 3.525)
Elderly (≥60 years old) 1.039 (0.992 – 1.088)
Gender
Male Reference
Female 1.177 (1.131 – 1.226)
Health insurance
UCS Reference
SSS 1.200 (1.106 – 1.302)
CSMBS 1.030 (0.982 – 1.079)
Others 1.075 (0.946 – 1.221)
Charlson’s co-morbidity index 1.067 (1.055 – 1.079)
Number of medication patients received
<5 medications Reference
≥5 medications 2.625 (2.507 – 2.748)
Type of hospital
District hospital Reference
Regional hospital 1.235 (0.056 – 27.027)
Abbreviations: CSMBS civil servant medical benefit schemes, SSS social security
schemes, UCS universal coverage schemes.
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was not much difference in the prevalence of patients
having a medication oversupply across different types of
health insurance. However, the average financial loss due
to medication oversupply in patients under the CSMBS
was about 2 times higher than patients under the UCS
and SSS. This was likely due to the mechanism of reim-
bursement. The hospitals can be fully reimbursed by
direct billing to the comptroller general's department,
which is a government organization paying for patients
under the CSMBS. Since providers have no concerns
about the financial burden to patients, they may pre-
scribe higher-cost medications to patients under the
CSMBS. Moreover, patients have no concern about the
amount of medications prescribed because there is no
out-of-pocket cost for them.
After adjustment for other variables in the same re-
gression, there were 2 factors which were strongly asso-
ciated with having a medication oversupply: age and
number of medications. Children had a 3.3 higher risk
of having a medication oversupply than the adults non-
elderly patients. The prevalence of children visiting
hospitals was likely to be greater than adult patients.
The patients visiting the hospital more often were likely
to receive the same medications that they receivedpreviously than patients visiting the hospital less often.
That might increase the chance of having a medication
oversupply. The second factor associated with medica-
tion oversupply was using more than 5 medications. Pa-
tients receiving at least 5 medications had a 2.6 higher
risk of having a medication oversupply than patients re-
ceiving fewer than 5 medications. It is possible that the
patients receiving more medications had more chronic
conditions and potentially more severe conditions; they
therefore might need to visit the hospital more often
than patients with less severe diseases. Again, the pa-
tients visiting the hospital more often are likely to re-
ceive the same medications that they received previously
than patients visiting the hospital less often, which
will increase the chance of experiencing a medication
oversupply.
There are other factors which might cause a medica-
tion oversupply than the factors we found in this study.
The poor medication management system might be a
major cause of medication oversupply. The medication
management system, such as outpatient medication rec-
onciliation, might not be appropriately implemented.
Thus, there might be no information about the amount
of medication that the patients received. Lack of an ap-
propriate communication system among healthcare pro-
viders may be another major cause—it increases the
chance of receiving the same medications from different
clinics, which can result in medication oversupply.
In this study, we used the MPRm > 1.20 as our oper-
ational definition. This definition allows 20% excessive
amount of medication supply for each patient. It helps
policy makers to better understand the magnitude of the
problem and its financial loss when they allow some
additional medication for patient to cover their medication
loss or delayed refill. Even though, patients are allowed to
receive 20% excessive medication, there are still about 14%
of patients had medication oversupply. The definition
emphasized inappropriately over-excessive amount of the
medication patients received and indicated inappropriate
financial loss due to medication oversupply. Policy makers
might use our findings to consider how much the budget
might be saved when considering only over-excessive
medication oversupply.
Several strategies or policies could potentially be imple-
mented for preventing medication oversupply. An effect-
ive outpatient medication reconciliation and medication
refill system should be considered because they are not
costly strategies but are likely to be effective. A previous
study [30] conducted to determine potential strategies to
prevent unnecessary loss due to medication oversupply
in Thailand also suggested that an effective outpatient
medication reconciliation and medication refill system
should be considered. Moreover, those strategies may be
useful for other purposes such as preventing inappropriate
Dilokthornsakul et al. BMC Health Services Research 2014, 14:408 Page 8 of 9
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of a high prevalence of medication oversupply and also
high financial burdens at regional hospitals, the above-
mentioned strategies should be implemented at re-
gional hospitals. Specifically, children or patients with
poly-pharmacy should be targeted since they are more
likely to have medication oversupply than others.
Another strategy suggested for preventing medication
oversupply is an effective computer system, one that is set
up to detect medication oversupply. However, this system
is likely to be more expensive than the outpatient medica-
tion reconciliation or medication refill system. The com-
puter system should be considered later if outpatient
medication reconciliation or medication refill systems are
not effective.
Some limitations of this study should be recognized.
First, these findings were based on the electronic data-
bases of 3 hospitals and might not be representative of all
hospitals in Thailand. The generalizabilty of these current
findings to other hospitals is limited and interpretation
should be done with cautions. Second, these findings relied
on electronic databases and a misclassification could have
occurred. However, these hospitals have used the data for
claiming purposes and we believe that the data used in this
study were credible. Moreover, the databases from the dis-
trict hospital were assessed for the quality of data, resulting
in both high specificity and sensitivity. Third, the definition
of patients receiving medication oversupply that we used
was that patients had a medication oversupply if the MPRm
for any medication was >1.20. The result would likely have
been different if we used a different definition of patients
receiving a medication oversupply. However, we decided to
use this definition because we thought that any medication
that patients were oversupplied with reflected the fact that
there were some problems in the system, leading to the lack
of ability to detect the excessive amount of medication that
the patients received. Last, because of data limitation we
could not fully understand the reasons behind the high bur-
den in regional hospitals. This warrants future research
investigation.
Conclusion
This study emphasized that medication oversupply is an
important problem in Thailand. Policy-makers should
consider the development of policies to decrease the
problem. Further policies might focus on regional hospi-
tals and patients under the CSMBS.
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